Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE recommends Revlimid as multiple myeloma alternative

pharmatimesMay 20, 2019

Tag: NICE , multiple myeloma , REVLIMID

PharmaSources Customer Service